clinical trial · NCT06701396
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology DisordersGene Mutations and Other Alterations NecTasimelteonPlacebo
brief summary
This is a double-blind, randomized, two-period crossover study to evaluate the efficacy and safety of a single oral dose of tasimelteon and matching placebo in male and female subjects with DSWPD and the CRY1Δ11 variant.
started
Oct 8, 2024
primary completion
Jun 30, 2025
completion
Jun 30, 2025
last updated
Nov 22, 2024
official title
A Double-Blind, Randomized, Two-Period Crossover Study to Evaluate the Effects of Tasimelteon Vs. Placebo in Subjects with Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol